Unknown

Dataset Information

The relation between inflammatory biomarkers and drug pharmacokinetics in the critically ill patients: a scoping review.


ABSTRACT:

Background

The level of inflammation alters drug pharmacokinetics (PK) in critically ill patients. This might compromise treatment efficacy. Understanding the specific effects of inflammation, measured by biomarkers, on drug absorption, distribution, metabolism, and excretion is might help in optimizing dosing strategies.

Objectives

This review investigates the relationship between inflammatory biomarkers and PK parameters absorption, distribution, metabolism and excretion (ADME) in critically ill patients, providing insight in the complexity of dosing drugs in critically ill patients.

Method

Following PRISMA guidelines, we conducted a comprehensive search of Medline, Embase, Web of Science, and Cochrane databases (January 1946-November 2023). Studies examining inflam

SUBMITTER: Li L 

PROVIDER: S-EPMC11577668 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature